Tapewire

Nasdaq · USD

PSNL

Personalis, Inc.

Export transactions ↓
Tapewire entity
4572
SEC CIK
0001527753
Parsed reports
288

Last 12 months

Inside the activity.

12 purchase rows · 16 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202582
Dec 202540
Jan 202601
Feb 202600
Mar 202600
Apr 202600
May 202603
Jun 202604
Jul 202602
Aug 202600
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 15, 2026 Filed Mar 17, 2026 20:59 UTC
Tachibana AaronCFO AND COO
GrantCommon Stock 34,375 $0.00 $0.00
Disclosure

SEC source: 0001401786-26-000003 · form4-03172026_080312.xml · nonDerivative · entry 1

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,833

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 6 equal semi-annual installments with the first installment vesting on September 15, 2026.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 20:54 UTC
Chen RichardPresident and CMO
GrantStock Option (right to buy) · Derivative 281,250 $0.00 Strike: $6.72 $0.00
Disclosure

SEC source: 0001779787-26-000002 · form4-03172026_080357.xml · derivative · entry 2

Chen Richard · CIK 0001779787 · President and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 281,250

Underlying: Common Stock · 281,250 shares

Expires 2036-03-15

F3 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2026.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 20:54 UTC
Chen RichardPresident and CMO
GrantCommon Stock 46,875 $0.00 $0.00
Disclosure

SEC source: 0001779787-26-000002 · form4-03172026_080357.xml · nonDerivative · entry 1

Chen Richard · CIK 0001779787 · President and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,880

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 6 equal semi-annual installments with the first installment vesting on September 15, 2026.

F2 · balance_after: Includes 2,500 shares acquired under the Issuer's Employee Stock Purchase Plan on October 31, 2025.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 20:57 UTC
Moore Stephen MichaelSVP and Chief Legal Officer
GrantStock Option (right to buy) · Derivative 168,750 $0.00 Strike: $6.72 $0.00
Disclosure

SEC source: 0001915342-26-000002 · form4-03172026_080346.xml · derivative · entry 2

Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 168,750

Underlying: Common Stock · 168,750 shares

Expires 2036-03-15

F2 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2026.

Read SEC document
March 15, 2026 Filed Mar 17, 2026 20:57 UTC
Moore Stephen MichaelSVP and Chief Legal Officer
GrantCommon Stock 28,125 $0.00 $0.00
Disclosure

SEC source: 0001915342-26-000002 · form4-03172026_080346.xml · nonDerivative · entry 1

Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,325

F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 6 equal semi-annual installments with the first installment vesting on September 15, 2026.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 23:47 UTC
Hall Christopher MDirector · PRESIDENT AND CEO
GrantStock Option (right to buy) · Derivative 33,333 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001449535-26-000001 · form4-02252026_110220.xml · derivative · entry 1

Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,333

Underlying: Common Stock · 33,333 shares

Expires 2034-03-15

F1 · balance_after: This amount represents the vesting of a performance stock option granted on March 15, 2024, following the satisfaction of a specified reimbursement milestone.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 23:51 UTC
Tachibana AaronCFO AND COO
GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001401786-26-000002 · form4-02252026_110223.xml · derivative · entry 1

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-03-15

F1 · balance_after: This amount represents the vesting of a performance stock option granted on March 15, 2024, following the satisfaction of a specified reimbursement milestone.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 23:50 UTC
Chen RichardCHIEF MEDICAL OFFICER AND EVP
GrantStock Option (right to buy) · Derivative 15,000 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001779787-26-000001 · form4-02252026_110211.xml · derivative · entry 1

Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2034-03-15

F1 · balance_after: This amount represents the vesting of a performance stock option granted on March 15, 2024, following the satisfaction of a specified reimbursement milestone.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 23:48 UTC
Moore Stephen MichaelSVP and Chief Legal Officer
GrantStock Option (right to buy) · Derivative 8,333 $0.00 Strike: $1.61 $0.00
Disclosure

SEC source: 0001915342-26-000001 · form4-02252026_110252.xml · derivative · entry 1

Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,333

Underlying: Common Stock · 8,333 shares

Expires 2034-03-15

F1 · balance_after: This amount represents the vesting of a performance stock option granted on March 15, 2024, following the satisfaction of a specified reimbursement milestone.

Read SEC document
January 22, 2026 Filed Jan 23, 2026 23:03 UTC
Tachibana AaronCFO AND COO
Exercise / conversionStock Option (right to buy) · Derivative 1,201 $0.00 Strike: $9.16 $0.00
Disclosure

SEC source: 0001401786-26-000001 · form4-01232026_110156.xml · derivative · entry 3

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,631

Underlying: Common Stock · 1,201 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025.

F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
January 22, 2026 Filed Jan 23, 2026 23:03 UTC
Tachibana AaronCFO AND COO
SaleCommon Stock 1,201 $11.50 $13,811.50
Disclosure

SEC source: 0001401786-26-000001 · form4-01232026_110156.xml · nonDerivative · entry 2

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,458

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025.

Read SEC document
January 22, 2026 Filed Jan 23, 2026 23:03 UTC
Tachibana AaronCFO AND COO
Exercise / conversionCommon Stock 1,201 $9.16 $11,001.16
Disclosure

SEC source: 0001401786-26-000001 · form4-01232026_110156.xml · nonDerivative · entry 1

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,659

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025.

Read SEC document
December 22, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 28,000 $8.93 $250,040.00
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 12

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,039,067

F12 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.73 to $9.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F12 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.73 to $9.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
December 19, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 29,641 $8.39 $248,687.99
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 11

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,011,067

F11 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.09 to $8.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F11 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.09 to $8.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
December 18, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 31,430 $7.91 $248,611.30
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 10

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,981,426

F10 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.80 to $8.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F10 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.80 to $8.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
December 17, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 31,650 $7.86 $248,769.00
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 9

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,949,996

F9 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.75 to $7.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F9 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.75 to $7.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 25, 2025 Filed Nov 28, 2025 22:09 UTC
Tachibana AaronCFO AND COO
Exercise / conversionStock Option (right to buy) · Derivative 103,668 $0.00 Strike: $9.16 $0.00
Disclosure

SEC source: 0001401786-25-000004 · form4-11282025_101141.xml · derivative · entry 3

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,832

Underlying: Common Stock · 103,668 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025.

F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable.

Read SEC document
November 25, 2025 Filed Nov 28, 2025 22:09 UTC
Tachibana AaronCFO AND COO
SaleCommon Stock 103,668 $10.78 $1,117,541.04
Disclosure

SEC source: 0001401786-25-000004 · form4-11282025_101141.xml · nonDerivative · entry 2

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,458

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025.

F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $10.25 to $11.10 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
November 25, 2025 Filed Nov 28, 2025 22:09 UTC
Tachibana AaronCFO AND COO
Exercise / conversionCommon Stock 103,668 $9.16 $949,598.88
Disclosure

SEC source: 0001401786-25-000004 · form4-11282025_101141.xml · nonDerivative · entry 1

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,126

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025.

Read SEC document
November 25, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 13,888 $11.00 $152,768.00
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 8

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,918,346

F8 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $10.47 to $11.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F8 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $10.47 to $11.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 25, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 9,712 $10.08 $97,896.96
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 7

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,904,458

F7 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.47 to $10.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F7 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.47 to $10.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 24, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 25,225 $9.87 $248,970.75
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 6

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,894,746

F6 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.69 to $10.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F6 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.69 to $10.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 21, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 16,599 $9.74 $161,674.26
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 5

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,869,521

F5 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.48 to $9.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F5 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.48 to $9.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 21, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 9,900 $8.84 $87,516.00
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 4

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,852,922

F4 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.40 to $9.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F4 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.40 to $9.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 20, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 28,827 $8.63 $248,777.01
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 3

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,843,022

F3 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.28 to $9.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F3 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.28 to $9.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 19, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 30,645 $8.12 $248,837.40
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 2

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,814,195

F2 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.80 to $8.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.80 to $8.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 18, 2025 Filed Feb 13, 2026 22:24 UTC PurchaseCommon Stock 64,750 $7.67 $496,632.50
Disclosure

SEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 1

Tempus AI, Inc. · CIK 0001717115 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,783,550

F1 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.36 to $7.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F1 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.36 to $7.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 03, 2025 Filed Nov 5, 2025 21:05 UTC
Hall Christopher MDirector · PRESIDENT AND CEO
SaleCommon Stock 29,612 $8.99 $266,211.88
Disclosure

SEC source: 0001449535-25-000004 · form4-11052025_041103.xml · nonDerivative · entry 1

Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,486

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $8.78 to $9.56 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
July 28, 2025 Filed Jul 30, 2025 20:20 UTC
Tachibana AaronCFO AND COO
SaleCommon Stock 641 $6.57 $4,211.37
Disclosure

SEC source: 0001415889-25-020571 · form4-07302025_040701.xml · nonDerivative · entry 1

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,458

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

Read SEC document
July 28, 2025 Filed Jul 30, 2025 20:20 UTC
Chen RichardCHIEF MEDICAL OFFICER AND EVP
SaleCommon Stock 452 $6.57 $2,969.64
Disclosure

SEC source: 0001415889-25-020572 · form4-07302025_040703.xml · nonDerivative · entry 1

Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,505

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:13 UTC GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $4.95 $0.00
Disclosure

SEC source: 0001415889-25-013794 · form4-05202025_080543.xml · derivative · entry 1

BOWMAN A BLAINE · CIK 0001008891 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-05-16

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:15 UTC GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $4.95 $0.00
Disclosure

SEC source: 0001415889-25-013799 · form4-05202025_080544.xml · derivative · entry 1

WIDDER KENNETH J · CIK 0001065168 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-05-16

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:16 UTC
Shoff LonnieDirector
GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $4.95 $0.00
Disclosure

SEC source: 0001415889-25-013800 · form4-05202025_080550.xml · derivative · entry 1

Shoff Lonnie · CIK 0001471716 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-05-16

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control.

Read SEC document
May 16, 2025 Filed May 20, 2025 21:53 UTC
Tachibana AaronCFO AND COO
SaleCommon Stock 1,291 $4.95 $6,390.45
Disclosure

SEC source: 0001415889-25-013848 · form4-05202025_090507.xml · nonDerivative · entry 1

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,099

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $4.85 to $5.05 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:12 UTC GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $4.95 $0.00
Disclosure

SEC source: 0001415889-25-013791 · form4-05202025_080503.xml · derivative · entry 1

MYERS WOODROW A JR · CIK 0001243399 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-05-16

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:14 UTC GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $4.95 $0.00
Disclosure

SEC source: 0001415889-25-013797 · form4-05202025_080545.xml · derivative · entry 1

EASTHAM KARIN · CIK 0001231845 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-05-16

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:18 UTC GrantStock Option (right to buy) · Derivative 50,000 $0.00 Strike: $4.95 $0.00
Disclosure

SEC source: 0001415889-25-013801 · form4-05202025_080517.xml · derivative · entry 1

Bloom Olivia Kyusuk · CIK 0001501545 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-05-16

F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control.

Read SEC document
May 16, 2025 Filed May 20, 2025 21:51 UTC
Moore Stephen MichaelSVP and Chief Legal Officer
SaleCommon Stock 1,675 $4.95 $8,291.25
Disclosure

SEC source: 0001415889-25-013847 · form4-05202025_090547.xml · nonDerivative · entry 1

Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,200

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $4.85 to $5.05 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
May 16, 2025 Filed May 20, 2025 21:50 UTC
Chen RichardCHIEF MEDICAL OFFICER AND EVP
SaleCommon Stock 910 $4.95 $4,504.50
Disclosure

SEC source: 0001415889-25-013846 · form4-05202025_090557.xml · nonDerivative · entry 1

Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,957

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $4.85 to $5.05 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F3 · balance_after: Includes 2,500 shares acquired under the Issuer's Employee Stock Purchase Plan on April 30, 2025.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 20:44 UTC
Hall Christopher MDirector · PRESIDENT AND CEO
GrantStock Option (right to buy) · Derivative 680,000 $0.00 Strike: $3.63 $0.00
Disclosure

SEC source: 0001415889-25-008427 · form4-03182025_080340.xml · derivative · entry 1

Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 680,000

Underlying: Common Stock · 680,000 shares

Expires 2035-03-15

F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2025.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 20:50 UTC
Tachibana AaronCFO AND COO
GrantStock Option (right to buy) · Derivative 250,000 $0.00 Strike: $3.63 $0.00
Disclosure

SEC source: 0001415889-25-008434 · form4-03182025_080309.xml · derivative · entry 1

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2035-03-15

F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2025.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 20:46 UTC
Moore Stephen MichaelSVP and Chief Legal Officer
GrantStock Option (right to buy) · Derivative 225,000 $0.00 Strike: $3.63 $0.00
Disclosure

SEC source: 0001415889-25-008431 · form4-03182025_080345.xml · derivative · entry 1

Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2035-03-15

F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2025.

Read SEC document
March 15, 2025 Filed Mar 18, 2025 20:41 UTC
Chen RichardCHIEF MEDICAL OFFICER AND EVP
GrantStock Option (right to buy) · Derivative 250,000 $0.00 Strike: $3.63 $0.00
Disclosure

SEC source: 0001415889-25-008415 · form4-03182025_080321.xml · derivative · entry 1

Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2035-03-15

F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2025.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 22:01 UTC
Tachibana AaronCFO AND COO
SaleCommon Stock 708 $5.79 $4,099.32
Disclosure

SEC source: 0001415889-25-002398 · form4-01302025_100132.xml · nonDerivative · entry 1

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,390

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

Read SEC document
January 28, 2025 Filed Jan 30, 2025 21:59 UTC
Chen RichardCHIEF MEDICAL OFFICER AND EVP
SaleCommon Stock 519 $5.79 $3,005.01
Disclosure

SEC source: 0001415889-25-002386 · form4-01302025_090150.xml · nonDerivative · entry 1

Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,367

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:25 UTC
Tachibana AaronCFO AND COO
SaleCommon Stock 6,865 $3.82 $26,224.30
Disclosure

SEC source: 0001415889-24-029736 · form4-12182024_041201.xml · nonDerivative · entry 1

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,098

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.65 to $3.91 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:35 UTC
Chen RichardCHIEF MEDICAL OFFICER AND EVP
SaleCommon Stock 4,834 $3.82 $18,465.88
Disclosure

SEC source: 0001415889-24-029741 · form4-12182024_041201.xml · nonDerivative · entry 1

Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,886

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.65 to $3.91 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
December 16, 2024 Filed Dec 18, 2024 21:30 UTC
Moore Stephen MichaelSVP and Chief Legal Officer
SaleCommon Stock 1,513 $3.82 $5,779.66
Disclosure

SEC source: 0001415889-24-029739 · form4-12182024_041203.xml · nonDerivative · entry 1

Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,875

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.65 to $3.91 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
November 18, 2024 Filed Nov 20, 2024 21:19 UTC
Tachibana AaronCFO AND COO
SaleCommon Stock 1,307 $3.79 $4,953.53
Disclosure

SEC source: 0001415889-24-027347 · form4-11202024_091113.xml · nonDerivative · entry 1

Tachibana Aaron · CIK 0001401786 · CFO AND COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,963

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.76 to $3.79 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
November 18, 2024 Filed Nov 20, 2024 21:14 UTC
Chen RichardCHIEF MEDICAL OFFICER AND EVP
SaleCommon Stock 921 $3.79 $3,490.59
Disclosure

SEC source: 0001415889-24-027338 · form4-11202024_091153.xml · nonDerivative · entry 1

Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,720

F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units.

F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.76 to $3.79 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F3 · balance_after: Includes 2,414 shares acquired under the Issuer's Employee Stock Purchase Plan on October 31, 2024.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.